CVS suspends sale of Zantac in response to FDA alert, giving refunds to customers

News

CVS Pharmacy announced Saturday that it has suspended the sale of all Zantac brand and other heartburn medications with ranitidine.

The announcement comes in response to an alert from the FDA saying that certain heartburn medications could contain a possible human carcinogen, causing cancer.

These products have not been recalled and the FDA is not recommending patients to stop taking these products.

But, they say customers can return the products to a CVS for a refund.

CVS adds they’ll continue to sell other heartburn medications, like Pepcid and Tagamet.

Copyright 2020 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't Miss

More Don't Miss